Bjørn Møller

4.5k total citations · 2 hit papers
41 papers, 2.8k citations indexed

About

Bjørn Møller is a scholar working on Oncology, Economics and Econometrics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Bjørn Møller has authored 41 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Oncology, 10 papers in Economics and Econometrics and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Bjørn Møller's work include Global Cancer Incidence and Screening (24 papers), Colorectal Cancer Screening and Detection (23 papers) and Economic and Financial Impacts of Cancer (6 papers). Bjørn Møller is often cited by papers focused on Global Cancer Incidence and Screening (24 papers), Colorectal Cancer Screening and Detection (23 papers) and Economic and Financial Impacts of Cancer (6 papers). Bjørn Møller collaborates with scholars based in Norway, Sweden and United Kingdom. Bjørn Møller's co-authors include Freddie Bray, Inger Kristin Larsen, Tom Børge Johannesen, Milada Cvancarova Småstuen, Donald Maxwell Parkin, Frøydis Langmark, Tor Haldorsen, Harald Weedon‐Fekjær, Timo Hakulinen and Hans H. Storm and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Bjørn Møller

40 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Human Papillomavirus Infection as a Risk Factor for Squamous-Cell Carcinoma of the Head and Neck

2001 717 citations Jon Mork, A. Kathrine Lie et al. New England Journal of Medicine profile →
Data quality at the Cancer Registry of Norway: An overview of comparability, completeness, validity and timeliness

2008 678 citations Inger Kristin Larsen, Milada Cvancarova Småstuen et al. European Journal of Cancer profile →

Peers

Countries citing papers authored by Bjørn Møller

Since Specialization

Citations

This map shows the geographic impact of Bjørn Møller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bjørn Møller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bjørn Møller more than expected).

Fields of papers citing papers by Bjørn Møller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bjørn Møller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bjørn Møller. The network helps show where Bjørn Møller may publish in the future.

Co-authorship network of co-authors of Bjørn Møller

This figure shows the co-authorship network connecting the top 25 collaborators of Bjørn Møller. A scholar is included among the top collaborators of Bjørn Møller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bjørn Møller. Bjørn Møller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Improving communication of cancer survival statistics—feasibility of implementing model-based algorithms in routine publications 2023 ·British Journal of Cancer ·Tor Åge Myklebust, Bjarte Aagnes, Yngvar Nilssen, Mark J. Rutherford, Paul C. Lambert, Therése Andersson, Anna L.V. Johansson, Paul W. Dickman, Bjørn Møller	1
2	Non-parametric estimation of reference adjusted, standardised probabilities of all-cause death and death due to cancer for population group comparisons 2022 ·BMC Medical Research Methodology ·Mark J. Rutherford, Therése Andersson, Tor Åge Myklebust, Bjørn Møller, Paul C. Lambert	4
3	Compliance with recommended cancer patient pathway timeframes and choice of treatment differed by cancer type and place of residence among cancer patients in Norway in 2015–2016 2022 ·BMC Cancer ·Yngvar Nilssen, Odd Terje Brustugun, Morten Eriksen, Marianne G. Guren, Erik Skaaheim Haug, Bjørn Naume, Ellen Schlichting, Bjørn Møller	1
4	Factors associated with emergency-onset diagnosis, time to treatment and type of treatment in colorectal cancer patients in Norway 2021 ·BMC Cancer ·Yngvar Nilssen, Morten Eriksen, Marianne G. Guren, Bjørn Møller	13
5	Patient and tumour characteristics associated with inclusion in Cancer patient pathways in Norway in 2015–2016 2020 ·BMC Cancer ·Yngvar Nilssen, Odd Terje Brustugun, Morten Eriksen, Erik Skaaheim Haug, Bjørn Naume, Bjørn Møller	15
6	A 61% lighter cell culture dish to reduce plastic waste 2019 ·PLoS ONE ·Pedro Réu, (unknown), (unknown), Bjørn Møller, Helene Andersson Svahn, Jesper Gantelius	5
7	Increase in curative treatment and survival of lung cancer in Norway 2001–2016 2019 ·European Journal of Epidemiology ·Steinar Solberg, Yngvar Nilssen, Odd Terje Brustugun, Tom K. Grimsrud, Per Magnus Haram, (unknown), Åslaug Helland, Harald Hjelde, (unknown), Bjørn Møller, (unknown), Trond‐Eirik Strand, Sissel Gyrid Freim Wahl, Marianne Aanerud, Lars Fjellbirkeland	14
8	Is time from diagnosis to radical prostatectomy associated with oncological outcomes? 2018 ·World Journal of Urology ·(unknown), Sophie D. Fosså, Rune Kvåle, Bjørn Møller, Tor Åge Myklebust, Ljiljana Vlatkovic, Stig Müller, Viktor Berge	14
9	How Many Deaths from Colorectal Cancer Can Be Prevented by 2030? A Scenario-Based Quantification of Risk Factor Modification, Screening, and Treatment in Norway 2017 ·Cancer Epidemiology Biomarkers & Prevention ·Katrine Damgaard Skyrud, Tor Åge Myklebust, Freddie Bray, Morten Eriksen, Thomas de Lange, Inger Kristin Larsen, Bjørn Møller	10
10	Proportion cured models applied to 23 cancer sites in Norway 2012 ·International Journal of Cancer ·Milada Cvancarova, Bjarte Aagnes, Sophie D. Fosså, Paul C. Lambert, Bjørn Møller, Freddie Bray	23
11	Epidemiology of pancreatic cancer in Norway: trends in incidence, basis of diagnosis and survival 1965–2007 2009 ·Scandinavian Journal of Gastroenterology ·Kjetil Søreide, Bjarte Aagnes, Bjørn Møller, Arne Westgaard, Freddie Bray	32
12	Data quality at the Cancer Registry of Norway: An overview of comparability, completeness, validity and timeliness breakdown → 2008 ·European Journal of Cancer ·Inger Kristin Larsen, Milada Cvancarova Småstuen, Tom Børge Johannesen, Frøydis Langmark, Donald Maxwell Parkin, Freddie Bray, Bjørn Møller	678
13	[Epidemiology of colorectal cancer in Norway]. 2007 ·PubMed ·Freddie Bray, Arne Wibe, Liv Marit Dørum, Bjørn Møller	10
14	Use of hormone therapy and risk of breast cancer detected at screening and between mammographic screens 2006 ·International Journal of Cancer ·Solveig Hofvind, Bjørn Møller, Steinar Thoresen, Giske Ursin	29
15	Early life events and later risk of colorectal cancer: age-period-cohort modelling in the Nordic countries and Estonia 2005 ·Cancer Causes & Control ·Elisabeth Svensson, Bjørn Møller, Steinar Tretli, Lotti Barlow, Gerda Engholm, Eero Pukkala, Mati Rahu, Laufey Tryggvadóttír	34
16	Predicting the future burden of cancer 2005 ·Nature reviews. Cancer ·Freddie Bray, Bjørn Møller	371
17	The influence of mammographic screening on national trends in breast cancer incidence 2005 ·European Journal of Cancer Prevention ·Bjørn Møller, Harald Weedon‐Fekjær, Timo Hakulinen, Laufey Tryggvadóttír, Hans H. Storm, Mats Talbäck, Tor Haldorsen	63
18	Prediction of cancer incidence in the Nordic countries: empirical comparison of different approaches 2003 ·Statistics in Medicine ·Bjørn Møller, Harald Weedon‐Fekjær, Timo Hakulinen, Helgi Sigvaldason, Hans H. Storm, Mats Talbäck, Tor Haldorsen	252
19	Human Papillomavirus Infection as a Risk Factor for Squamous-Cell Carcinoma of the Head and Neck breakdown → 2001 ·New England Journal of Medicine ·Jon Mork, A. Kathrine Lie, Eystein Glattre, Sarah L. Clark, Göran Hallmans, Egil Jellum, Pentti Koskela, Bjørn Møller, Eero Pukkala, John T. Schiller, Zhaohui Wang, Linda Youngman, Matti Lehtinen, Joakim Dillner	717
20	Biochemical analysis of bovine lens sections obtained by a new sectioning device. 1989 ·PubMed ·(unknown), (unknown), Bjørn Møller, I. Körte, O. Hockwin	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact